位置:首页 > 蛋白库 > M2_I72A8
M2_I72A8
ID   M2_I72A8                Reviewed;          97 AA.
AC   P0DOF8; P03490; P63231; Q1K9D8;
DT   10-MAY-2017, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2017, sequence version 1.
DT   02-JUN-2021, entry version 33.
DE   RecName: Full=Matrix protein 2 {ECO:0000255|HAMAP-Rule:MF_04069};
DE   AltName: Full=Proton channel protein M2 {ECO:0000255|HAMAP-Rule:MF_04069};
GN   Name=M {ECO:0000255|HAMAP-Rule:MF_04069};
OS   Influenza A virus (strain A/Udorn/1972 H3N2).
OC   Viruses; Riboviria; Orthornavirae; Negarnaviricota; Polyploviricotina;
OC   Insthoviricetes; Articulavirales; Orthomyxoviridae; Alphainfluenzavirus.
OX   NCBI_TaxID=385599;
OH   NCBI_TaxID=8782; Aves.
OH   NCBI_TaxID=9721; Cetacea (whales).
OH   NCBI_TaxID=9606; Homo sapiens (Human).
OH   NCBI_TaxID=9709; Phocidae (true seals).
OH   NCBI_TaxID=9823; Sus scrofa (Pig).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=6945577; DOI=10.1073/pnas.78.7.4170;
RA   Lamb R.A., Lai C.-J., Choppin P.W.;
RT   "Sequences of mRNAs derived from genome RNA segment 7 of influenza virus:
RT   colinear and interrupted mRNAs code for overlapping proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:4170-4174(1981).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=7257189; DOI=10.1016/0042-6822(81)90319-6;
RA   Lamb R.A., Lai C.-J.;
RT   "Conservation of the influenza virus membrane protein (M1) amino acid
RT   sequence and an open reading frame of RNA segment 7 encoding a second
RT   protein (M2) in H1N1 and H3N2 strains.";
RL   Virology 112:746-751(1981).
RN   [3]
RP   DISULFIDE BONDS, AND SUBUNIT.
RX   PubMed=2053285; DOI=10.1016/0042-6822(91)90115-r;
RA   Holsinger L.J., Lamb R.A.;
RT   "Influenza virus M2 integral membrane protein is a homotetramer stabilized
RT   by formation of disulfide bonds.";
RL   Virology 183:32-43(1991).
RN   [4]
RP   FUNCTION, AND MUTAGENESIS OF VAL-27; ALA-30; SER-31; GLY-34 AND TRP-41.
RX   PubMed=7508997; DOI=10.1128/jvi.68.3.1551-1563.1994;
RA   Holsinger L.J., Nichani D., Pinto L.H., Lamb R.A.;
RT   "Influenza A virus M2 ion channel protein: a structure-function analysis.";
RL   J. Virol. 68:1551-1563(1994).
RN   [5]
RP   PHOSPHORYLATION AT SER-64; SER-82; SER-89 AND SER-93, AND MUTAGENESIS OF
RP   SER-64.
RX   PubMed=7529332; DOI=10.1128/jvi.69.2.1219-1225.1995;
RA   Holsinger L.J., Shaughnessy M.A., Micko A., Pinto L.H., Lamb R.A.;
RT   "Analysis of the posttranslational modifications of the influenza virus M2
RT   protein.";
RL   J. Virol. 69:1219-1225(1995).
RN   [6]
RP   INTERACTION WITH MATRIX PROTEIN 1.
RX   PubMed=16873274; DOI=10.1128/jvi.00627-06;
RA   McCown M.F., Pekosz A.;
RT   "Distinct domains of the influenza a virus M2 protein cytoplasmic tail
RT   mediate binding to the M1 protein and facilitate infectious virus
RT   production.";
RL   J. Virol. 80:8178-8189(2006).
RN   [7]
RP   REVIEW.
RX   PubMed=12972146; DOI=10.1016/s0014-5793(03)00778-6;
RA   Lear J.D.;
RT   "Proton conduction through the M2 protein of the influenza A virus; a
RT   quantitative, mechanistic analysis of experimental data.";
RL   FEBS Lett. 552:17-22(2003).
RN   [8]
RP   REVIEW.
RX   PubMed=12972147; DOI=10.1016/s0014-5793(03)00779-8;
RA   Wu Y., Voth G.A.;
RT   "Computational studies of proton transport through the M2 channel.";
RL   FEBS Lett. 552:23-27(2003).
RN   [9]
RP   REVIEW.
RX   PubMed=15567494; DOI=10.1016/j.virusres.2004.08.012;
RA   Nayak D.P., Hui E.K., Barman S.;
RT   "Assembly and budding of influenza virus.";
RL   Virus Res. 106:147-165(2004).
CC   -!- FUNCTION: Forms a proton-selective ion channel that is necessary for
CC       the efficient release of the viral genome during virus entry. After
CC       attaching to the cell surface, the virion enters the cell by
CC       endocytosis. Acidification of the endosome triggers M2 ion channel
CC       activity. The influx of protons into virion interior is believed to
CC       disrupt interactions between the viral ribonucleoprotein (RNP), matrix
CC       protein 1 (M1), and lipid bilayers, thereby freeing the viral genome
CC       from interaction with viral proteins and enabling RNA segments to
CC       migrate to the host cell nucleus, where influenza virus RNA
CC       transcription and replication occur. Also plays a role in viral
CC       proteins secretory pathway. Elevates the intravesicular pH of normally
CC       acidic compartments, such as trans-Golgi network, preventing newly
CC       formed hemagglutinin from premature switching to the fusion-active
CC       conformation (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:7508997}.
CC   -!- FUNCTION: Forms a proton-selective ion channel that is necessary for
CC       the efficient release of the viral genome during virus entry. After
CC       attaching to the cell surface, the virion enters the cell by
CC       endocytosis. Acidification of the endosome triggers M2 ion channel
CC       activity. The influx of protons into virion interior is believed to
CC       disrupt interactions between the viral ribonucleoprotein (RNP), matrix
CC       protein 1 (M1), and lipid bilayers, thereby freeing the viral genome
CC       from interaction with viral proteins and enabling RNA segments to
CC       migrate to the host cell nucleus, where influenza virus RNA
CC       transcription and replication occur. Also plays a role in viral
CC       proteins secretory pathway. Elevates the intravesicular pH of normally
CC       acidic compartments, such as trans-Golgi network, preventing newly
CC       formed hemagglutinin from premature switching to the fusion-active
CC       conformation. {ECO:0000255|HAMAP-Rule:MF_04069}.
CC   -!- ACTIVITY REGULATION: The M2 protein from most influenza A strains is
CC       inhibited by amantadine and rimantadine, resulting in viral uncoating
CC       incapacity. Emergence of amantadine-resistant variants is usually
CC       rapid.
CC   -!- SUBUNIT: Homotetramer; composed of two disulfide-linked dimers held
CC       together by non-covalent interactions (PubMed:2053285). May interact
CC       with matrix protein 1 (PubMed:16873274). {ECO:0000255|HAMAP-
CC       Rule:MF_04069, ECO:0000269|PubMed:16873274,
CC       ECO:0000269|PubMed:2053285}.
CC   -!- SUBCELLULAR LOCATION: Virion membrane {ECO:0000255|HAMAP-
CC       Rule:MF_04069}. Host apical cell membrane {ECO:0000255|HAMAP-
CC       Rule:MF_04069}; Single-pass type III membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_04069}. Note=Abundantly expressed at the
CC       apical plasma membrane in infected polarized epithelial cells, in close
CC       proximity to budding and assembled virions. Minor component of virions
CC       (only 16-20 molecules/virion). {ECO:0000255|HAMAP-Rule:MF_04069}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Only the first 9 residues are shared by the 2 isoforms.;
CC       Name=M2;
CC         IsoId=P0DOF8-1, P03490-1, P63231-1;
CC         Sequence=Displayed;
CC       Name=M1;
CC         IsoId=P0DOF7-1, P03486-1, P63233-1;
CC         Sequence=External;
CC   -!- DOMAIN: Cytoplasmic tail plays an important role in virion assembly and
CC       morphogenesis. {ECO:0000255|HAMAP-Rule:MF_04069}.
CC   -!- MISCELLANEOUS: When the channel is activated, one or more imidazole
CC       moieties of His-37 probably become bi-protonated. {ECO:0000255|HAMAP-
CC       Rule:MF_04069}.
CC   -!- SIMILARITY: Belongs to the influenza viruses matrix protein M2 family.
CC       {ECO:0000255|HAMAP-Rule:MF_04069}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02167; AAA43303.1; -; Genomic_RNA.
DR   SMR; P0DOF8; -.
DR   ChEMBL; CHEMBL2052; -.
DR   iPTMnet; P0DOF8; -.
DR   Proteomes; UP000171580; Genome.
DR   GO; GO:0020002; C:host cell plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-UniRule.
DR   GO; GO:0044385; C:integral to membrane of host cell; IEA:UniProtKB-UniRule.
DR   GO; GO:0055036; C:virion membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005216; F:ion channel activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0015078; F:proton transmembrane transporter activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0039707; P:pore formation by virus in membrane of host cell; IEA:UniProtKB-UniRule.
DR   GO; GO:0051259; P:protein complex oligomerization; IEA:UniProtKB-UniRule.
DR   GO; GO:0039521; P:suppression by virus of host autophagy; IEA:UniProtKB-UniRule.
DR   HAMAP; MF_04069; INFV_M2; 1.
DR   InterPro; IPR002089; Flu_M2.
DR   Pfam; PF00599; Flu_M2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disulfide bond; Glycoprotein; Host cell membrane;
KW   Host membrane; Host-virus interaction; Hydrogen ion transport;
KW   Inhibition of host autophagy by virus; Ion channel; Ion transport;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Signal-anchor;
KW   Transmembrane; Transmembrane helix; Transport; Viral ion channel; Virion.
FT   CHAIN           1..97
FT                   /note="Matrix protein 2"
FT                   /id="PRO_0000078892"
FT   TOPO_DOM        1..22
FT                   /note="Virion surface"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04069"
FT   TRANSMEM        23..43
FT                   /note="Helical; Signal-anchor for type III membrane
FT                   protein"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04069"
FT   TOPO_DOM        44..97
FT                   /note="Intravirion"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04069"
FT   REGION          60..88
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        67..88
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            37
FT                   /note="Essential for channel activity, possibly by being
FT                   protonated during channel activation, and by forming the
FT                   channel gate and the selective filter"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04069"
FT   SITE            41
FT                   /note="Seems to be involved in pH gating"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04069"
FT   SITE            71
FT                   /note="Not phosphorylated"
FT   MOD_RES         64
FT                   /note="Phosphoserine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04069,
FT                   ECO:0000269|PubMed:7529332"
FT   MOD_RES         82
FT                   /note="Phosphoserine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04069,
FT                   ECO:0000269|PubMed:7529332"
FT   MOD_RES         89
FT                   /note="Phosphoserine; by host"
FT                   /evidence="ECO:0000269|PubMed:7529332"
FT   MOD_RES         93
FT                   /note="Phosphoserine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04069,
FT                   ECO:0000269|PubMed:7529332"
FT   LIPID           50
FT                   /note="S-palmitoyl cysteine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04069"
FT   CARBOHYD        20
FT                   /note="N-linked (GlcNAc...) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04069"
FT   DISULFID        17
FT                   /note="Interchain (with C-17)"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04069,
FT                   ECO:0000269|PubMed:2053285"
FT   DISULFID        19
FT                   /note="Interchain (with C-19)"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04069,
FT                   ECO:0000269|PubMed:2053285"
FT   MUTAGEN         27
FT                   /note="V->A: Increased channel activity. Resistant to
FT                   amantatine."
FT                   /evidence="ECO:0000269|PubMed:7508997"
FT   MUTAGEN         27
FT                   /note="V->S: Increased channel activity. Resistant to
FT                   amantatine."
FT                   /evidence="ECO:0000269|PubMed:7508997"
FT   MUTAGEN         27
FT                   /note="V->T: Increased channel activity."
FT                   /evidence="ECO:0000269|PubMed:7508997"
FT   MUTAGEN         30
FT                   /note="A->P: Almost complete loss of channel activity.
FT                   Resistant to amantatine."
FT                   /evidence="ECO:0000269|PubMed:7508997"
FT   MUTAGEN         30
FT                   /note="A->T: Greatly reduced channel activity. Resistant to
FT                   amantatine."
FT                   /evidence="ECO:0000269|PubMed:7508997"
FT   MUTAGEN         31
FT                   /note="S->N: No effect on channel activity. Resistant to
FT                   amantatine."
FT                   /evidence="ECO:0000269|PubMed:7508997"
FT   MUTAGEN         34
FT                   /note="G->E: Increased channel activity. Resistant to
FT                   amantatine."
FT                   /evidence="ECO:0000269|PubMed:7508997"
FT   MUTAGEN         41
FT                   /note="W->A: Almost complete loss of channel activity."
FT                   /evidence="ECO:0000269|PubMed:7508997"
FT   MUTAGEN         64
FT                   /note="S->A: 85% reduction in phosphate labeling of M2
FT                   protein."
FT                   /evidence="ECO:0000269|PubMed:7529332"
SQ   SEQUENCE   97 AA;  11186 MW;  3CDD4DE90D7B16A4 CRC64;
     MSLLTEVETP IRNEWGCRCN DSSDPLVVAA SIIGILHLIL WILDRLFFKC IYRFFEHGLK
     RGPSTEGVPE SMREEYRKEQ QSAVDADDSH FVSIELE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024